SE421692B - Analogiforfarande for framstellning av spiro(cyklopropan-1,2Ÿ-indolin)-3Ÿ-on-foreningar - Google Patents

Analogiforfarande for framstellning av spiro(cyklopropan-1,2Ÿ-indolin)-3Ÿ-on-foreningar

Info

Publication number
SE421692B
SE421692B SE7613218A SE7613218A SE421692B SE 421692 B SE421692 B SE 421692B SE 7613218 A SE7613218 A SE 7613218A SE 7613218 A SE7613218 A SE 7613218A SE 421692 B SE421692 B SE 421692B
Authority
SE
Sweden
Prior art keywords
indoline
cyclopropane
spiro
compounds
preparation
Prior art date
Application number
SE7613218A
Other languages
English (en)
Swedish (sv)
Other versions
SE7613218L (sv
Inventor
S Noguchi
S Takei
Y Kawano
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7613218L publication Critical patent/SE7613218L/xx
Publication of SE421692B publication Critical patent/SE421692B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7613218A 1975-11-26 1976-11-25 Analogiforfarande for framstellning av spiro(cyklopropan-1,2Ÿ-indolin)-3Ÿ-on-foreningar SE421692B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50141748A JPS5265267A (en) 1975-11-26 1975-11-26 Synthesis of spiro compounds

Publications (2)

Publication Number Publication Date
SE7613218L SE7613218L (sv) 1977-05-27
SE421692B true SE421692B (sv) 1982-01-25

Family

ID=15299270

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613218A SE421692B (sv) 1975-11-26 1976-11-25 Analogiforfarande for framstellning av spiro(cyklopropan-1,2Ÿ-indolin)-3Ÿ-on-foreningar

Country Status (12)

Country Link
US (1) US4105670A (xx)
JP (1) JPS5265267A (xx)
AU (1) AU499472B2 (xx)
BE (1) BE848766A (xx)
CA (1) CA1091656A (xx)
CH (1) CH623811A5 (xx)
DE (1) DE2653477A1 (xx)
DK (1) DK526476A (xx)
FR (1) FR2362125A1 (xx)
GB (1) GB1570596A (xx)
NL (1) NL7613187A (xx)
SE (1) SE421692B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284644A (en) * 1977-01-12 1981-08-18 Takeda Chemical Industries, Ltd. Spirobenzofuranone compounds
US4342779A (en) * 1977-12-27 1982-08-03 Takeda Chemical Industries, Ltd. 7-Acetylspirobenzofuranone compound
JPS5646879A (en) * 1979-09-25 1981-04-28 Takeda Chem Ind Ltd Spiro compound, its preparation, and preventive and remedy for circulatory system disorder
US4330554A (en) * 1980-04-23 1982-05-18 Takeda Chemical Industries, Ltd. Spirobenzofuranone compounds
FR2501676A1 (fr) * 1981-03-11 1982-09-17 Rhone Poulenc Spec Chim Procede de n-alkylation de composes organiques azotes
CA2589363A1 (en) * 2004-12-13 2006-06-22 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors

Also Published As

Publication number Publication date
DE2653477A1 (de) 1977-06-08
NL7613187A (nl) 1977-05-31
BE848766A (fr) 1977-05-25
AU499472B2 (en) 1979-04-26
FR2362125A1 (fr) 1978-03-17
JPS5265267A (en) 1977-05-30
DK526476A (da) 1977-05-27
AU1997476A (en) 1978-06-01
CA1091656A (en) 1980-12-16
US4105670A (en) 1978-08-08
SE7613218L (sv) 1977-05-27
FR2362125B1 (xx) 1982-07-09
GB1570596A (en) 1980-07-02
CH623811A5 (xx) 1981-06-30

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE422941B (sv) Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
NO144209C (no) Fremgangsmaate for fremstilling av dialkylkarbonater
SE438853B (sv) Forfarande for framstellning av 2-azetidinonforeningar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
DK138749C (da) Analogifremgangsmaade til fremstilling af 18-methyl-4,15-oestradiener
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
SE421692B (sv) Analogiforfarande for framstellning av spiro(cyklopropan-1,2Ÿ-indolin)-3Ÿ-on-foreningar
SE443142B (sv) Forfarande for framstellning av rifamycinforeningar
SE409717B (sv) Forfarande for framstellning av 1alfa,25-dihydroxi-cholekalciferol
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE409455B (sv) Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7605427L (sv) Forfarande for framstellning av klorcyan